| Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses H Pan, R Peto, AMH Restrepo, MP Preziosi, V Sathiyamoorthy, QA Karim, ... The Lancet 399 (10339), 1941-1953, 2022 | 253 | 2022 |
| Non-COVID-19 visits to emergency departments during the pandemic: the impact of fear G Mantica, N Riccardi, C Terrone, A Gratarola Public health 183, 40, 2020 | 227 | 2020 |
| Tuberculosis and COVID-19 co-infection: description of the global cohort TB/COVID-19 Global Study Group European Respiratory Journal 59 (3), 2022 | 135 | 2022 |
| Tick-borne encephalitis in Europe: a brief update on epidemiology, diagnosis, prevention, and treatment N Riccardi, RM Antonello, R Luzzati, J Zajkowska, S Di Bella, ... European journal of internal medicine 62, 1-6, 2019 | 123 | 2019 |
| Efficacy of bamlanivimab/etesevimab and casirivimab/imdevimab in preventing progression to severe COVID-19 and role of variants of concern M Falcone, G Tiseo, B Valoriani, C Barbieri, S Occhineri, P Mazzetti, ... Infectious diseases and therapy 10 (4), 2479-2488, 2021 | 92 | 2021 |
| History of schistosomiasis (bilharziasis) in humans: from Egyptian medical papyri to molecular biology on mummies S Di Bella, N Riccardi, DR Giacobbe, R Luzzati Pathogens and global health 112 (5), 268-273, 2018 | 67 | 2018 |
| A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks’ observational data AF Capetti, MV Cossu, G Orofino, G Sterrantino, G Cenderello, ... BMC Infectious Diseases 17, 1-7, 2017 | 57 | 2017 |
| Sensitivity, specificity and predictive values of molecular and serological tests for COVID-19: a longitudinal study in emergency room Z Bisoffi, E Pomari, M Deiana, C Piubelli, N Ronzoni, A Beltrame, G Bertoli, ... Diagnostics 10 (9), 669, 2020 | 56 | 2020 |
| Efficacy and safety of nirmatrelvir/ritonavir, molnupiravir, and remdesivir in a real-world cohort of outpatients with COVID-19 at high risk of progression: the PISA outpatient … G Tiseo, C Barbieri, V Galfo, S Occhineri, T Matucci, F Almerigogna, ... Infectious Diseases and Therapy 12 (1), 257-271, 2023 | 44 | 2023 |
| Effect of HIV-infection on QuantiFERON-plus accuracy in patients with active tuberculosis and latent infection E Petruccioli, T Chiacchio, A Navarra, V Vanini, G Cuzzi, C Cimaglia, ... Journal of Infection 80 (5), 536-546, 2020 | 43 | 2020 |
| Diagnosis and clinical management of hepatosplenic schistosomiasis: A scoping review of the literature F Tamarozzi, VA Fittipaldo, HM Orth, J Richter, D Buonfrate, N Riccardi, ... PLoS neglected tropical diseases 15 (3), e0009191, 2021 | 37 | 2021 |
| Mycobacterium chimaera infections: An update N Riccardi, J Monticelli, RM Antonello, R Luzzati, M Gabrielli, M Ferrarese, ... Journal of Infection and Chemotherapy 26 (3), 199-205, 2020 | 37 | 2020 |
| HIV and tuberculosis: The paradox of dual illnesses and the challenges of their fighting in the history D Canetti, N Riccardi, M Martini, S Villa, A Di Biagio, L Codecasa, ... Tuberculosis 122 (January), 2020 | 37 | 2020 |
| Definition of opportunistic infections in immunocompromised children on the basis of etiologies and clinical features: a summary for practical purposes N Riccardi, GA Rotulo, E Castagnola Current pediatric reviews 15 (4), 197-206, 2019 | 34 | 2019 |
| Delay in schistosomiasis diagnosis and treatment: a multicenter cohort study in Italy A Comelli, N Riccardi, D Canetti, M Spinicci, G Cenderello, P Magro, ... Journal of travel medicine 27 (1), taz075, 2020 | 29 | 2020 |
| TB and COVID-19 co-infection: rationale and aims of a global study TB COVID, N Casco, AL Jorge, D Palmero, JW Alffenaar, G Fox, W Ezz, ... International Journal of Tuberculosis and Lung Disease 25 (1), 78-80, 2021 | 28 | 2021 |
| Increasing prevalence of genitourinary schistosomiasis in Europe in the Migrant Era: Neglected no more? N Riccardi, F Nosenzo, F Peraldo, F Sarocchi, L Taramasso, P Traverso, ... PLoS neglected tropical diseases 11 (3), e0005237, 2017 | 28 | 2017 |
| Clofazimine: an old drug for never-ending diseases N Riccardi, A Giacomelli, D Canetti, A Comelli, E Intini, G Gaiera, ... Future Microbiology 15 (7), 557-566, 2020 | 27 | 2020 |
| The impact of the SARS-CoV-2 outbreak on the psychological flexibility and behaviour of cancelling medical appointments of Italian patients with pre-existing medical condition … G Deledda, N Riccardi, S Gori, S Poli, M Giansante, E Geccherle, C Mazzi, ... International Journal of Environmental Research and Public Health 18 (1), 340, 2021 | 25 | 2021 |
| Multisystem inflammatory syndrome in an adult (MIS-A) successfully treated with anakinra and glucocorticoids P Cattaneo, A Volpe, CS Cardellino, N Riccardi, G Bertoli, T Ursini, ... Microorganisms 9 (7), 1393, 2021 | 24 | 2021 |
